DK2531222T3 - Liposomer indeholdende prostaglandin e1 (pge1), formuleringer indeholdende dem og deres anvendelse - Google Patents
Liposomer indeholdende prostaglandin e1 (pge1), formuleringer indeholdende dem og deres anvendelseInfo
- Publication number
- DK2531222T3 DK2531222T3 DK11709472.2T DK11709472T DK2531222T3 DK 2531222 T3 DK2531222 T3 DK 2531222T3 DK 11709472 T DK11709472 T DK 11709472T DK 2531222 T3 DK2531222 T3 DK 2531222T3
- Authority
- DK
- Denmark
- Prior art keywords
- pge1
- prostaglandin
- liposomes
- formulations
- formulations containing
- Prior art date
Links
- GMVPRGQOIOIIMI-UHFFFAOYSA-N (8R,11R,12R,13E,15S)-11,15-Dihydroxy-9-oxo-13-prostenoic acid Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CCCCCCC(O)=O GMVPRGQOIOIIMI-UHFFFAOYSA-N 0.000 title 2
- 229960000711 alprostadil Drugs 0.000 title 2
- GMVPRGQOIOIIMI-DWKJAMRDSA-N prostaglandin E1 Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O GMVPRGQOIOIIMI-DWKJAMRDSA-N 0.000 title 2
- XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 title 2
- 239000002502 liposome Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
- A61K47/6911—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a liposome
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITFI2010A000013A IT1397867B1 (it) | 2010-02-03 | 2010-02-03 | Liposomi contenenti prostaglandina e1 (pge1), formulazioni che li contengono e loro uso |
| PCT/IB2011/050463 WO2011095938A1 (en) | 2010-02-03 | 2011-02-03 | Liposomes containing prostaglandin e1 (pge1), formulations containing them and their use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2531222T3 true DK2531222T3 (da) | 2014-06-23 |
Family
ID=42357658
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK11709472.2T DK2531222T3 (da) | 2010-02-03 | 2011-02-03 | Liposomer indeholdende prostaglandin e1 (pge1), formuleringer indeholdende dem og deres anvendelse |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20130039975A1 (da) |
| EP (1) | EP2531222B1 (da) |
| CN (1) | CN102811745B (da) |
| BR (1) | BR112012019344A2 (da) |
| CA (1) | CA2787725A1 (da) |
| DK (1) | DK2531222T3 (da) |
| ES (1) | ES2477233T3 (da) |
| IT (1) | IT1397867B1 (da) |
| WO (1) | WO2011095938A1 (da) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITRM20120036A1 (it) * | 2012-02-02 | 2013-08-03 | Robert Davis Steigerwalt Jr | Applicazione transdermica di prostaglandina e1 per il trattamento dell¿ischemia oculare. |
| ITFI20120092A1 (it) * | 2012-05-14 | 2013-11-15 | Giovanni Brotzu | Liposomi contenenti prostaglandina e1 (pge1) ed un estrogeno vegetale, formulazioni per uso topico che li contengono e loro uso. |
| HUE037543T2 (hu) * | 2014-05-06 | 2018-09-28 | Fidia Farm Spa | Di-homo-gamma linolénsavat (DGLA) tartalmazó liposzómák, az azokat tartalmazó készítmények és alkalmazásuk |
| CN107049942A (zh) * | 2016-12-30 | 2017-08-18 | 北京普德康利医药科技发展有限公司 | 一种前列地尔注射液 |
| IT201700059875A1 (it) * | 2017-05-31 | 2018-12-01 | Univ Degli Studi Cagliari | Complessi a base di fosfolipidi, fibre idrosolubili e principi attivi antiossidanti di origine naturale, loro preparazione e uso in formulazioni orali |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4311707A (en) * | 1979-02-12 | 1982-01-19 | American Cyanamid Company | Process for topically producing cutaneous vasodilation for the treatment of vasospastic or ischemic conditions |
| US4661105A (en) * | 1981-06-29 | 1987-04-28 | Alza Corporation | Medical bandage for administering vasodilator drug |
| US4846826A (en) * | 1981-07-22 | 1989-07-11 | Alza Corporation | Method for treating ischemic conditions |
| AU617678B2 (en) * | 1987-05-22 | 1991-12-05 | Liposome Company, Inc., The | Prostaglandin-lipid formulations |
| US5811118A (en) * | 1987-05-22 | 1998-09-22 | The Liposome Company, Inc. | Methods of treatment using unilamellar liposomal arachidonic acid metabolite formulations |
| US5853755A (en) * | 1993-07-28 | 1998-12-29 | Pharmaderm Laboratories Ltd. | Biphasic multilamellar lipid vesicles |
| ITRM20010708A1 (it) * | 2001-12-04 | 2003-06-04 | Sigma Tau Ind Farmaceuti | Uso di una alcanoil l-carnitina per il trattamento della disfunzione erettile. |
-
2010
- 2010-02-03 IT ITFI2010A000013A patent/IT1397867B1/it active
-
2011
- 2011-02-03 WO PCT/IB2011/050463 patent/WO2011095938A1/en active Application Filing
- 2011-02-03 CN CN201180007198.0A patent/CN102811745B/zh not_active Expired - Fee Related
- 2011-02-03 CA CA2787725A patent/CA2787725A1/en not_active Abandoned
- 2011-02-03 ES ES11709472.2T patent/ES2477233T3/es active Active
- 2011-02-03 DK DK11709472.2T patent/DK2531222T3/da active
- 2011-02-03 US US13/574,426 patent/US20130039975A1/en not_active Abandoned
- 2011-02-03 EP EP11709472.2A patent/EP2531222B1/en not_active Not-in-force
- 2011-02-03 BR BR112012019344A patent/BR112012019344A2/pt not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2787725A1 (en) | 2011-08-11 |
| ITFI20100013A1 (it) | 2011-08-04 |
| CN102811745A (zh) | 2012-12-05 |
| BR112012019344A2 (pt) | 2019-09-24 |
| IT1397867B1 (it) | 2013-02-04 |
| US20130039975A1 (en) | 2013-02-14 |
| WO2011095938A1 (en) | 2011-08-11 |
| CN102811745B (zh) | 2015-07-01 |
| ES2477233T3 (es) | 2014-07-16 |
| EP2531222A1 (en) | 2012-12-12 |
| EP2531222B1 (en) | 2014-04-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3127540T3 (da) | Visse amino-pyrimidiner, sammensætninger deraf, og fremgangsmåder til deres anvendelse | |
| DK3170508T3 (da) | Vaccineformuleringer | |
| DK2875005T3 (da) | N-(3-heteroarylaryl)-4-arylarylcarboxamider og analoger som hedgehog pathway inhibitorer, og anvendelse deraf | |
| DK2648809T3 (da) | Naturlige formuleringer | |
| DK2841429T3 (da) | Tetrazolinonforbindelser og anvendelse deraf som pesticider | |
| DK3130347T3 (da) | PH20-polypeptidvarianter, formuleringer og anvendelser deraf | |
| DK2707384T3 (da) | Cellereaktiv, langtidsvirkende eller målrettede compstatinanaloger og anvendelser deraf | |
| GT201200303A (es) | Formulaciones farmacéuticas | |
| BR112013008864A2 (pt) | análogos d ciclosporina | |
| DK2823810T3 (da) | Amfotere liposomer, der omfatter iminolipider | |
| ZA201208286B (en) | Use of formulations having insecticidal activity | |
| EP2755680A4 (en) | PARTICULATE VACCINE FORMULATIONS | |
| DK2531222T3 (da) | Liposomer indeholdende prostaglandin e1 (pge1), formuleringer indeholdende dem og deres anvendelse | |
| BR112013019687A2 (pt) | antraquinona contendo preparações/formulações de lignina. | |
| DK2439188T3 (da) | P-menthan-3,8-diolderivater og insektbeskyttelsesmidler, der indeholder dem | |
| CO6801767A2 (es) | Formulaciones de liberación sostenida de paracetamol | |
| DK2881108T3 (da) | Forbedrede medicinske aerosolformuleringer | |
| ZA201305986B (en) | Improved insecticide formulations | |
| DK2521715T3 (da) | Piperaziner som antimalariamidler | |
| FR2967069B3 (fr) | Formulations | |
| DK2598472T3 (da) | Formuleringer | |
| GB201113974D0 (en) | Stable vitamin c formulations | |
| ITRM20110583A1 (it) | Formulazioni. | |
| ES1074265Y (es) | Disfraz | |
| UA20719S (uk) | Розбризкувач |